
Deloitte: Open Innovation Success Rate 3 Times Higher Than In-house R&D
The Knowledge website reported that the knowledge intensity and speed of biotechnology has shifted the locus of innovation to a network rather than within any single firm. This is causing pharmaceutical firms to look for new ways to tap into innovative sources of drug development outside their organizational boundaries and they are increasingly engaging
Comments Off on Deloitte: Open Innovation Success Rate 3 Times Higher Than In-house R&D • Read this story »
More Articles

Innovation Begins With Open Practices
The Opensource.com website noted that today’s firms all face increased competition and dynamic markets. Yesterday’s big bang can easily become today’s cautionary tale. Strategically, the only viable response to this disruption is constantly striving to serve customers better through
Comments Off on Innovation Begins With Open Practices • Read this story »